Inferior Vena cavaCollapsibility Index in Patients With Acute Kidney Injury

Acute Kidney Injury Clinical Trial

Official title:

Inferior Vena Cava Collapsibility Index in Patients With Acute Kidney Injury

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02165072
• Other study ID #: L14-052
• Status: Completed
• Phase: N/A
• First received: June 13, 2014
• Last updated: June 21, 2016
• Start date: February 2014
• Est. completion date: October 2015

Study information

• Verified date: June 2016
• Source: Texas Tech University Health Sciences Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

This is an observational study that will examine the possibility of determining the type of Acute Kidney Injury (AKI) using bedside ultrasound machines.

Description:

The investigators hypothesize that different types of AKI (pre-renal, renal, and post-renal) are associated with different inferior vena cava diameters and collapsibility index. The investigators will include subjects ages 18-89 years with AKI (creatinine of 2mg/100ml or higher for less than 24 hours from baseline creatinine ≤1.2 or with unknown baseline creatinine). Standard of care treatment will not be different for patients taking part in this study. Participants will have bedside ultrasounds on days 0, 1, and 3, and baseline and follow-up data will be collected from medical records.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: October 2015
• Est. primary completion date: October 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 89 Years

Eligibility

Inclusion Criteria:

1. Creatinine of 1.7 mg/100ml or higher for less than 24 hours from baseline creatinine =1.2 or with unknown baseline creatinine

2. Age range: 18-89 years

3. Age range = 18

Exclusion Criteria:

1. Only chronic renal disease will exclude a patient from our study regardless of past medical history and medications they are taking. (For the purposes of this study, any patient with creatinine higher than 1.2 mg /100ml for more than 24 hours will be identified as having chronic renal disease.)

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Acute Kidney Injury

Locations

Country	Name	City	State
United States	Texas Tech Univrsity Health Science Center	Lubbock	Texas

Sponsors (1)

Lead Sponsor	Collaborator
Texas Tech University Health Sciences Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Maximum and Minimum Diameters of the Inferior Vena Cava in Patients With Acute Kidney Injury	The investigators will measure the maximum and minimum diameters of the inferior vena cava with patients with acute kidney injury.	Day 1 of ICU admission	No
Primary	Percent Collapse of the Inferior Vena Cava in Patients With Acute Kidney Injury	The investigators will measure the maximum and minimum diameters of the inferior vena cava with patients with acute kidney injury and calculate the percent change between the maximum and minimum diameters.	Day 1 of ICU admission	No